Extended Chemotherapy for Residual Disease after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in High Risk Neuroblastoma

被引：0
|
作者：
Park, H. J. [1 ]
Choi, J. Y. [1 ]
Kang, H. J. [1 ]
Kim, B. K. [1 ]
Hong, K. T. [1 ]
Kim, H. -Y. [2 ]
Park, S. -H. [3 ]
Cheon, J. -E. [4 ]
Kim, I. H. [5 ]
Cheon, G. J. [6 ]
Shin, H. Y. [1 ]
机构：
[1] Seoul Natl Univ, Pediat, Coll Med, Seoul, South Korea
[2] Seoul Natl Univ, Pediat Surg, Coll Med, Seoul, South Korea
[3] Seoul Natl Univ, Pathol, Coll Med, Seoul, South Korea
[4] Seoul Natl Univ, Radiol, Coll Med, Seoul, South Korea
[5] Seoul Natl Univ, Radiat Oncol, Coll Med, Seoul, South Korea
[6] Seoul Natl Univ, Nucl Med, Coll Med, Seoul, South Korea
来源：
PEDIATRIC BLOOD & CANCER | 2020年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0588
引用
收藏
页码：S266 / S266
页数：1
相关论文
共 50 条
  • [31] Herpes zoster after high-dose chemotherapy and autologous stem cell transplantation.
    Fetscher, S
    Technau, K
    Lange, W
    BONE MARROW TRANSPLANTATION, 1999, 23 : S114 - S114
  • [32] Secondary malignancies after high-dose chemotherapy and autologous hematopoietic stem cell transplantation
    Fetscher, S
    Lange, W
    Finke, J
    Bertz, E
    Mertelsmann, R
    BLOOD, 1995, 86 (10) : 3768 - 3768
  • [33] Infectious complications after high-dose chemotherapy and autologous stem cell transplantation.
    Reich, G
    Mapara, MY
    Reichardt, P
    Dörken, B
    Maschmeyer, G
    BLOOD, 1998, 92 (10) : 337B - 337B
  • [34] First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies
    Naumann-Winter, Frauke
    Greb, Alexander
    Borchmann, Peter
    Bohlius, Julia
    Engert, Andreas
    Schnell, Roland
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10):
  • [35] Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Grade Gliomas in Children and Adolescents
    Lee, Ji Won
    Lim, Do Hoon
    Sung, Ki Woong
    Lee, Hyeong Jin
    Yi, Eun Sang
    Yoo, Keon Hee
    Koo, Hong Hoe
    Suh, Yeon-Lim
    Shin, Hyung Jin
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (02) : 195 - 203
  • [36] Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma
    A Pession
    A Prete
    F Locatelli
    S Pierinelli
    AL Pession
    R Maccario
    E Magrini
    B De Bernardi
    P Paolucci
    G Paolucci
    British Journal of Cancer, 1998, 78 : 528 - 533
  • [37] Feasibility and Efficacy of Treatment Strategy of Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation with Incorporation of High-Dose 131I-MIBG Therapy for High-Risk Neuroblastoma
    Shin, J.
    Koh, K. N.
    Suh, J. K.
    Min, S.
    Kim, Y. S.
    Namgoon, J. M.
    Kim, D. Y.
    Ahn, S. D.
    Kim, H.
    Im, H. J.
    Seo, J. J.
    Kook, H.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S340 - S340
  • [38] High-dose chemotherapy and autologous stem cell transplantation as treatment for high-risk breast cancer
    Tallman, MS
    Gradishar, WJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (Suppl 1) : S60 - S67
  • [39] High-dose chemotherapy and autologous stem cell transplantation as treatment for high-risk breast cancer
    Martin S. Tallman
    William J. Gradishar
    Cancer Chemotherapy and Pharmacology, 1998, 42 : S60 - S67
  • [40] Hyperammonemia after high-dose chemotherapy and stem cell transplantation
    P Frere
    JL Canivet
    C Gennigens
    JP Rebeix
    G Fillet
    Y Beguin
    Bone Marrow Transplantation, 2000, 26 : 343 - 345
12345